Product Information
APTENSIO XR 30 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $8.0315 per EA under NDC 42858040445. Its NADAC has been published 259 times since Jun 20, 2018.
Strength
30 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858040445
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205831On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for APTENSIO XR 30 MG CAPSULE has been published 259 times since Jun 20, 2018, and over the history we have for it it has risen 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0315 per EA |
|---|---|
| All-time high | $8.0315 (Jun 24, 2026) |
| All-time low | $7.4943 (Jun 20, 2018) |
| 52-week high | $8.0315 |
| 52-week low | $8.0096 |
| Median price | $8.0047 |
| Average price | $7.8955 |
| Largest weekly change | +6.0% (Aug 7, 2019) |
| Weeks tracked | 259 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 77% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APTENSIO XR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 30 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $8.0315 per EA (NDC 42858040445), effective Jun 24, 2026.
How has the price of APTENSIO XR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APTENSIO XR 30 MG CAPSULE has risen 7.2%. It has been tracked across 259 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for APTENSIO XR 30 MG CAPSULE?
Since Jun 20, 2018, the NADAC for APTENSIO XR 30 MG CAPSULE has ranged from a low of $7.4943 (Jun 20, 2018) to a high of $8.0315 (Jun 24, 2026), with a median of $8.0047 per EA.
Are there cheaper alternatives to APTENSIO XR 30 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE CD 30 MG CAP, is $1.8150 per EA — about 77% below APTENSIO XR 30 MG CAPSULE.
Who manufactures APTENSIO XR 30 MG CAPSULE?
APTENSIO XR 30 MG CAPSULE (NDC 42858040445) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.
Related Drugs
Same classification